Log in to save to my catalogue

Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brent...

Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brent...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8082231

Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotin

About this item

Full title

Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotin

Publisher

England: Spandidos Publications

Journal title

Molecular and clinical oncology, 2021-06, Vol.14 (6), p.121-121, Article 121

Language

English

Formats

Publication information

Publisher

England: Spandidos Publications

More information

Scope and Contents

Contents

Primary cutaneous anaplastic large cell lymphoma (PCALCL) is a rare CD30
lymphoproliferative disorder characterized by the development of lesions ranging from papules to large tumors. Most cases present as localized disease, however multifocal and generalized involvement of the skin can occur. Several treatments have been proposed for PCALCL; ho...

Alternative Titles

Full title

Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8082231

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8082231

Other Identifiers

ISSN

2049-9450

E-ISSN

2049-9469

DOI

10.3892/mco.2021.2283

How to access this item